Get short, timely messages from The Oncologist.

Twitter is a rich source of instantly updated information. It's easy to stay updated on an incredibly wide variety of topics. Join today and follow @OncJournal.

Get updates via SMS by texting follow OncJournal to 40404 in the United States
Codes for other countries

Two-way (sending and receiving) short codes:
Country Code For customers of
Australia
  • 0198089488 Telstra
Canada
  • 21212 (any)
United Kingdom
  • 86444 Vodafone, Orange, 3, O2
Indonesia
  • 89887 AXIS, 3, Telkomsel
Ireland
  • 51210 O2
India
  • 53000 Bharti Airtel, Videocon
Jordan
  • 90903 Zain
New Zealand
  • 8987 Vodafone, Telecom NZ
United States
  • 40404 (any)

OncJournal

  1. Is there an interaction between methotrexate and proton pump inhibitors? bit.ly/JBdcn7 7:29 AM May 15th via TweetDeck
  2. What are the effects of tamoxifen on blood markers linked to cardiovascular risk in women on chemo for breast cancer? bit.ly/JzxrRg 7:29 AM May 14th via TweetDeck
  3. What is the effect of diabetes mellitus on breast cancer prognosis? bit.ly/JIHfHI 7:47 AM May 11th via TweetDeck
  4. Bevacizumab-Based Therapies in the First-Line Treatment of Metastatic Colorectal Cancer - bit.ly/Jim3Jc 12:47 PM May 10th via TweetDeck
  5. Efficacy and safety of bevacizumab, trastuzumab & capecitabine as first-line therapy for HER-2 positive breast cancer - bit.ly/Jfd5MO 8:25 AM May 9th via TweetDeck
  6. Catch up on your CME. New CME activities now available! bit.ly/dQIHC3 9:46 AM May 1st via TweetDeck
  7. Modeling the 5-U AUC-Dose relationship to develop a pharmacokinetic dosing algorithm for colorectal cancer - bit.ly/II0SNI 9:05 AM Apr 30th via TweetDeck
  8. What newer agents show clinical promise in the management of relapsed or refractory Hodgkin's lymphoma? bit.ly/Hy5YCe 8:57 AM Apr 25th via TweetDeck
  9. Phase II results of cetuximab plus capecitabine in elderly patients with advanced colorectal cancer. bit.ly/Hy0FTi 1:21 PM Apr 24th via TweetDeck
  10. A New Era for the Systemic Therapy of Neuroendocrine Tumors - bit.ly/IoUAXh 9:06 AM Apr 23rd via TweetDeck
  11. Modeling 5-FU AUC–Dose Relationship for colorectal cancer patients receiving FOLFOX6 bit.ly/II0SNI 8:00 AM Apr 19th via TweetDeck
  12. How can communication between HCPs and patients about early phase trial participation be improved? bit.ly/HyW3IU 12:40 PM Apr 17th via TweetDeck
  13. Effectiveness of TACE combined with sorafenib in delaying time to progression of intermediate-stage HCC. bit.ly/HytGML 9:03 AM Apr 17th via TweetDeck
  14. Targeted Therapy for Advanced Gastric Cancer: Are We Making Progress in the Era of Personalized Medicine? bit.ly/Hypb4F 1:48 PM Apr 16th via TweetDeck
  15. Scott M. Lippman, MD, Named New Director of UC San Diego Moores Cancer Center: health.ucsd.edu/news/releases/… 8:55 AM Apr 14th via Tweet Button
  16. What Is the Utility of Distal Forearm DXA in Primary Hyperparathyroidism? bit.ly/IoUqiA 7:19 AM Apr 12th via TweetDeck
  17. What are the variations in single nucleotide polymorphisms within 8q24 as risk factors for prostate cancer? bit.ly/HyIt7M 8:05 AM Apr 10th via TweetDeck
  18. Are outpatient oncology providers using teachable moments of cancer diagnosis to provide smoking cessation assistance? bit.ly/Hq337J 6:46 AM Apr 4th via TweetDeck
  19. Health Care Costs: How Do We Decide Value? When Do We Decide? How Do We Particularize the Decisions? bit.ly/xYQoaV 6:44 AM Mar 30th via TweetDeck
  20. What proportion of relapsed breast tumors have diff receptor status from primary tumor, altering treatment practice? bit.ly/AA7p5W 8:14 AM Mar 27th via TweetDeck
  • Name The Oncologist
  • Location Durham, NC, USA
  • Web http://www.theonc...
  • Bio The Oncologist Journal focuses on medical and practice issues of busy oncology, hematology and radiation professionals to aid in better cancer patient care.
158 Following 627 Followers 24 Listed